Fladrafinil was initially produced with the French pharmaceutical organization Lafon Laboratories during the seventies as aspect of their exploration into wakefulness-selling agents.This property is essential for preventing the deterioration of neuronal cells in disorders where oxidative pressure is a factor, such as growing old and neurodegenerati